Edwards Lifesciences Corp (EW)vsVicarious Surgical Inc. (RBOT)
EW
Edwards Lifesciences Corp
$82.67
+1.20%
HEALTHCARE · Cap: $48.01B
RBOT
Vicarious Surgical Inc.
$0.90
+2.27%
HEALTHCARE · Cap: $6.84M
Smart Verdict
WallStSmart Research — data-driven comparison
EW leads profitability with a 17.7% profit margin vs 0.0%. EW earns a higher WallStSmart Score of 55/100 (C).
EW
Buy55
out of 100
Grade: C
RBOT
Avoid29
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-544.4%
Fair Value
$12.31
Current Price
$82.67
$70.36 premium
Intrinsic value data unavailable for RBOT.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 23.7%
Reasonable price relative to book value
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 76.6%
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin. Profitability is solid with margins at 17.7% and operating margin at 23.7%. Revenue growth of 13.3% demonstrates continued momentum.
Bull Case : RBOT
The strongest argument for RBOT centers on Price/Book.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 45.7x leaves little room for execution misses.
Bear Case : RBOT
The primary concerns for RBOT are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
EW profiles as a mature stock while RBOT is a value play — different risk/reward profiles.
RBOT carries more volatility with a beta of 1.55 — expect wider price swings.
EW is growing revenue faster at 13.3% — sustainability is the question.
EW generates stronger free cash flow (354M), providing more financial flexibility.
Bottom Line
EW scores higher overall (55/100 vs 29/100), backed by strong 17.7% margins and 13.3% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Vicarious Surgical Inc.
HEALTHCARE · MEDICAL DEVICES · USA
Vicarious Surgical Inc. (RBOT) is an innovative medical technology company focused on transforming surgical practices through its state-of-the-art robotic surgical systems that enhance precision and improve patient outcomes. By combining advanced robotics with artificial intelligence, Vicarious Surgical is pioneering a new era of minimally invasive surgery, offering surgeons superior dexterity, visualization, and control. The company's proprietary platform not only enhances surgical efficiency but also strives to minimize patient recovery times, thereby responding to the increasing demand for robotic-assisted procedures. As a leader in the rapidly growing surgical robotics market, Vicarious Surgical is dedicated to advancing patient care and addressing the evolving challenges within the healthcare sector.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?